柳叶刀·Oncology-2012-June

柳叶刀_Oncology-2012-June.pdfComment Capecitabineinthetreatmentofrectalcancer as an oral substitute for intravenous fluorouracil inwith fluorouracil in a randomised trial.In The Lancet the 1990s.Since then, many phase 2 and 3 trials have Oncology, Hofheinz and colleagues report results of and stages, at various doses, and asComment In the neoadjuvant cohort, capecitabine chemo-Geerard L Beets,*Regina G H Beets-Tan chemoradiation; there were more pathological(RGHB-T),Maastricht University Medical Center, Maastricht, complete responses and more downstaging.This does Netherlands [email protected] pathways.Thus, the RAS and MAPK pathways might out-of-field(abscopal) to localised radiotherapy.The fall victim to sporadic activating mutations, such kinetics of the cellular immune changes and the time as V6ooE, which causes constitutive activation of to clinical response are consistent
———— 文字由OCR识别(未校验)，可能存在错字；请以原始完整版为准。